EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy

SIMPLE SUMMARY: EGFR exon 20 insertions are rare genetic alterations in non-small-cell lung cancers (NSCLCs) that are usually unresponsive to approved EGFR tyrosine kinase inhibitors (TKIs), but data is limited about this population. We aim to describe clinical features, survival, and response to ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Chelabi, Samy, Mignard, Xavier, Leroy, Karen, Monnet, Isabelle, Brosseau, Solenn, Theou-Anton, Nathalie, Massiani, Marie-Ange, Friard, Sylvie, Duchemann, Boris, Fabre, Elizabeth, Giroux-Leprieur, Etienne, Cadranel, Jacques, Wislez, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534282/
https://www.ncbi.nlm.nih.gov/pubmed/34680280
http://dx.doi.org/10.3390/cancers13205132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534282/
https://www.ncbi.nlm.nih.gov/pubmed/34680280
http://dx.doi.org/10.3390/cancers13205132

Ejemplares similares